The Nation - News from Oct. 20, 1986
- Share via
The first drug proved effective for obsessive-compulsive disorder is being obtained illegally in Canada by hundreds of Americans because it is not available here, Dr. Thomas Insel of the National Institute of Mental Health said at the annual meeting of the Phobia Society of America in New York City. Insel said surveys have found that about 5 million Americans suffer from the disorder. The drug, clomipramine, also called chlorimipramine, is in a category of drugs called tricyclic anti-depressants. It is available in Canada, Mexico and Europe, Insel said, but has not won approval by the U.S. Food and Drug Administration. Its manufacturer, Ciba Pharmaceutical Co. of Summit, N.J., has begun U.S. trials of the drug, Insel said.
More From the Los Angeles Times
Podcasts
In our first episode, the L.A. Times columnist George Skelton sizes up the governors he’s known, what made them successful and whether the next one can measure up.
On screen, Errol Flynn played a series of daredevils, fortune hunters, and suave romantics. Off screen, he lived a life of outsize debauchery and recklessness, including a persistent interest in underage girls. In 1943, at the height of his fame, he faced trial in Los Angeles on charges of statutory rape.
How do you get more people to care about climate change — and tell riveting stories along the way? Boiling Point explored that question at a live event during this year’s New York City Climate Week at Columbia University’s Climate School.
